[1]Bravo-Cordero JJ, Hodgson L, Condeelis J. Directed cell invasion and migration during metastasis[J]. Curr Opin Cell Biol, 2012, 24(2):277-283.
[2]Chiang AC, Massague J. Molecular basis of metastasis[J]. N Engl J Med, 2008, 359(26):2814-2823.
[3]Huang X, Yuan T, Tschannen M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing[J]. BMC Genomics, 2013, 14:319.
[4]Wu X, McMurray CT. Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein[J]. J Biol Chem, 2001, 276(3):1735-1741.
[5]Johannessen M, Delghandi MP, Moens U. What turns CREB on[J]? Cell Signal, 2004, 16(11):1211-1227.
[6]Boer U, Eglins J, Krause D, et al. Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain[J]. Biochem J, 2007, 408(1):69-77.
[7]Flammer JR, Popova KN, Pflum MK. Cyclic AMP response element-binding protein (CREB) and CAAT/enhancer-binding protein beta (C/EBPbeta) bind chimeric DNA sites with high affinity[J]. Biochemistry, 2006, 45(31):9615-9623.
[8]Impey S, McCorkle SR, Cha-Molstad H, et al. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions[J]. Cell, 2004, 119(7):1041-1054.[9]Kitagawa K, Sasaki T, Terasaki Y, et al. CREB activation is a key player for ischemic tolerance in the brain[J]. Rinsho Shinkeigaku, 2012, 52(11):904-907.
[10]Li L,Wang P.Cell apoptosis mediated by the transcription factor CAMP response element binding protein and its mechanism[J]. Acta Anatomica Sinica, 2012, 43(1):139-144. (in Chinese)
李垒, 王萍. 转录因子环腺苷酸反应元件结合蛋白介导的细胞凋亡及其调控机制[J]. 解剖学报, 2012, 43(1):139-144.
[11]Huang ShSh,Wang X,Zhuang HH,et al.Effects of cAMP response element binding protein on taxol-induced HeLa cell-cycle arrest[J]. Acta Anatomica Sinica, 2014, (4):485-492. (in Chinese)
黄帅帅, 王雪, 庄海慧, 等. 转录因子环磷酸腺苷反应元件结合蛋白在紫杉醇诱导HeLa细胞周期阻滞中的作用及其机制[J]. 解剖学报, 2014, (4):485-492.
[12]Wang P, Yan H, Li JC. CREB-mediated Bcl-2 expression in trichosanthin-induced HeLa cell apoptosis[J]. Biochem Biophys Res Commun, 2007, 363(1):101-105.
[13]Wang P, Xu J, Zhang C. CREB, a possible upstream regulator of Bcl-2 in trichosanthin-induced HeLa cell apoptosis[J]. Mol Biol Rep, 2010, 37(4):1891-1896.
[14]Wang P, Huang S, Wang F, et al. Cyclic AMP-response element regulated cell cycle arrests in cancer cells[J]. PLoS One, 2013, 8(6):e65661.
[15]Kang S, Elf S, Lythgoe K, et al. p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells[J]. J Clin Invest, 2010, 120(4):1165-1177.
[16]Zhang D, Ma QY, Hu HT, et al. Beta 2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFkappaB and AP-1[J]. Cancer Biol Ther, 2010, 10(1):19-29.
[17]Jean D, Bar-Eli M. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family[J]. Mol Cell Biochem, 2000, 212(12):19-28.
[18]Chien MH, Ying TH, Hsieh YS, et al. Dioscorea nipponica Makino inhibits migration and invasion of human oral cancer HSC-3 cells by transcriptional inhibition of matrix met alloproteinase-2 through modulation of CREB and AP-1 activity[J]. Food Chem Toxicol, 2012, 50(34):558-566.
[19]Park JK, Park SH, So K, et al. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB[J]. Int J Oncol, 2010, 36(1):181-192.
[20]Kedrin D, van Rheenen J, Hernandez L, et al. Cell motility and cytoskelet al regulation in invasion and metastasis[J]. J Mammary Gland Biol Neoplasia, 2007, 12(23):143-152.
[21]Scanlon CS, Van Tubergen EA, Inglehart RC, et al. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma[J]. J Dent Res, 2013, 92(2):114-121.
[22]Turley EA, Veiseh M, Radisky DC, et al. Mechanisms of disease: epithelial-mesenchymal transition—does cellular plasticity fuel neoplastic progression[J]? Nat Clin Pract Oncol, 2008, 5(5):280-290.
[23]Medema JP. Cancer stem cells: the challenges ahead[J]. Nat Cell Biol, 2013, 15(4):338-344.
[24]Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 2008, 133(4):704-715.
[25]Zhou B, Liu Y, Kahn M, et al. Interactions between beta-catenin and transforming growth factor-beta signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)[J]. J Biol Chem, 2012, 287(10):7026-7038.
[26]Wu D, Zhau HE, Huang WC, et al. cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis[J]. Oncogene, 2007, 26(35):5070-5077.
[27]Xu J, Wang R, Xie ZH, et al. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis[J]. Prostate, 2006, 66(15):1664-1673.
[28]Zhau HY, Chang SM, Chen BQ, et al. Androgen-repressed phenotype in human prostate cancer[J]. Proc Natl Acad Sci USA, 1996, 93(26):15152-15157.
[29]Yang AD, Camp ER, Fan F, et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells[J]. Cancer Res, 2006, 66(1):46-51.
[30]Singh R, Shankar BS, Sainis KB. TGF-beta1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells[J]. Cell Signal, 2014, 26(7):1604-1615.
[31]Burma S, Chen BP, Murphy M, et al. ATM phosphorylates histone H2AX in response to DNA double-strand breaks[J]. J Biol Chem, 2001, 276(45):42462-42467.
[32]Chiba N, Comaills V, Shiotani B, et al. Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responses[J]. Proc Natl Acad Sci USA, 2012, 109(8):2760-2765.
[33]Hansen C, Howlin J, Tengholm A, et al. Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner[J]. J Biol Chem, 2009, 284(40):27533-27543.
[34]Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion[J]. Biochim Biophys Acta, 2007, 1773(5):642-652.
[35]Jiang P, Enomoto A, Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton[J]. Cancer Lett, 2009, 284(2):122-130.
[36]Guasch RM, Tomas M, Minambres R, et al. RhoA and lysophosphatidic acid are involved in the actin cytoskeleton reorganization of astrocytes exposed to ethanol[J]. J Neurosci Res, 2003, 72(4):487-502.
[37]Hall A. The cytoskeleton and cancer[J]. Cancer Metastasis Rev, 2009, 28(1-2):5-14.
[38]Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility[J]. Clin Exp Metastasis, 2009, 26(4):273-287.
[39]Sit ST, Manser E. Rho GTPases and their role in organizing the actin cytoskeleton[J]. J Cell Sci, 2011, 124(Pt 5):679-683.
[40]Chava KR, Tauseef M, Sharma T, et al. Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression[J]. Blood, 2012, 119(1):308-319.
[41]Lesiak A, Pelz C, Ando H, et al. A genome-wide screen of CREB occupancy identifies the RhoA inhibitors Par6C and Rnd3 as regulators of BDNF-induced synaptogenesis[J]. PLoS One, 2013, 8(6):e64658.
[42]Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis[J]. Nat Cell Biol, 2010, 12(3):247-256.
[43]Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis[J]. Oncogene, 2010, 29(7):937-948.
[44]Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J]. Nature, 2007, 449(7163):682-688.
[45]Huang Q, Gumireddy K, Schrier M, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis[J]. Nat Cell Biol, 2008, 10(2):202-210.
[46]Negrini M, Calin GA. Breast cancer metastasis: a microRNA story[J]. Breast Cancer Res, 2008, 10(2):203.
[47]Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis[J]. Nature, 2008, 451(7175):147-152.
[48]Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis[J]. Proc Natl Acad Sci USA, 2008, 105(36):13556-13561.
[49]Sandoval S, Pigazzi M, Sakamoto KM. CREB: A key regulator of normal and neoplastic hematopoiesis[J]. Adv Hematol, 2009, 2009:634292-634299.
[50]Pigazzi M, Manara E, Bresolin S, et al. MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation[J]. Haematologica, 2013, 98(4):602-610.
[51]Zhu L, Chen H, Zhou D, et al. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility[J]. Med Oncol, 2012, 29(2):1037-1043.
[52]Tan X, Wang S, Yang B, et al. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells[J]. PLoS One, 2012, 7(11):e49570. |